BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37227305)

  • 1. PLOD2 promotes colorectal cancer progression by stabilizing USP15 to activate the AKT/mTOR signaling pathway.
    Lan J; Zhang S; Zheng L; Long X; Chen J; Liu X; Zhou M; Zhou J
    Cancer Sci; 2023 Aug; 114(8):3190-3202. PubMed ID: 37227305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-induced PLOD2 regulates invasion and epithelial-mesenchymal transition in endometrial carcinoma cells.
    Wan J; Qin J; Cao Q; Hu P; Zhong C; Tu C
    Genes Genomics; 2020 Mar; 42(3):317-324. PubMed ID: 31872384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipocyte-derived IL-6 and leptin promote breast Cancer metastasis via upregulation of Lysyl Hydroxylase-2 expression.
    He JY; Wei XH; Li SJ; Liu Y; Hu HL; Li ZZ; Kuang XH; Wang L; Shi X; Yuan ST; Sun L
    Cell Commun Signal; 2018 Dec; 16(1):100. PubMed ID: 30563531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-induced PLOD2 promotes proliferation, migration and invasion via PI3K/Akt signaling in glioma.
    Song Y; Zheng S; Wang J; Long H; Fang L; Wang G; Li Z; Que T; Liu Y; Li Y; Zhang X; Fang W; Qi S
    Oncotarget; 2017 Jun; 8(26):41947-41962. PubMed ID: 28410212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLOD2 regulated by transcription factor FOXA1 promotes metastasis in NSCLC.
    Du H; Chen Y; Hou X; Huang Y; Wei X; Yu X; Feng S; Wu Y; Zhan M; Shi X; Lin S; Lu L; Yuan S; Sun L
    Cell Death Dis; 2017 Oct; 8(10):e3143. PubMed ID: 29072684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLOD2 promotes aerobic glycolysis and cell progression in colorectal cancer by upregulating HK2.
    Du W; Liu N; Zhang Y; Liu X; Yang Y; Chen W; He Y
    Biochem Cell Biol; 2020 Jun; 98(3):386-395. PubMed ID: 31742425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-induced PLOD2 promotes clear cell renal cell carcinoma progression via modulating EGFR-dependent AKT pathway activation.
    Liu T; Xiang W; Chen Z; Wang G; Cao R; Zhou F; Meng Z; Luo Y; Chen L
    Cell Death Dis; 2023 Nov; 14(11):774. PubMed ID: 38008826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of PLOD2 in esophageal squamous cell carcinoma and its correlation with invasion and metastasis].
    Di WY; Kang XH; Zhang JH; Wang Y; Kou WZ; Su W
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):102-107. PubMed ID: 30695860
    [No Abstract]   [Full Text] [Related]  

  • 9. The Collagen-Modifying Enzyme PLOD2 Is Induced and Required during L1-Mediated Colon Cancer Progression.
    Cheriyamundath S; Kumar A; Gavert N; Brabletz T; Ben-Ze'ev A
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-secreted PAI-1 promotes breast cancer metastasis via the induction of adipocyte-derived collagen remodeling.
    Wei X; Li S; He J; Du H; Liu Y; Yu W; Hu H; Han L; Wang C; Li H; Shi X; Zhan M; Lu L; Yuan S; Sun L
    Cell Commun Signal; 2019 Jun; 17(1):58. PubMed ID: 31170987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
    Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLOD1 promotes cell growth and aerobic glycolysis by regulating the SOX9/PI3K/Akt/mTOR signaling pathway in gastric cancer.
    Zhang Y; Wu Y; Su X
    Front Biosci (Landmark Ed); 2021 Aug; 26(8):322-334. PubMed ID: 34455762
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma.
    Sun Y; Wang S; Zhang X; Wu Z; Li Z; Ding Z; Huang X; Chen S; Jing Y; Zhang X; Ding L; Song Y; Sun G; Ni Y
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hierarchical network of hypoxia-inducible factor and SMAD proteins governs procollagen lysyl hydroxylase 2 induction by hypoxia and transforming growth factor β1.
    Rosell-García T; Palomo-Álvarez O; Rodríguez-Pascual F
    J Biol Chem; 2019 Sep; 294(39):14308-14318. PubMed ID: 31391253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Upregulation of PLOD2 promotes invasion and metastasis of osteosarcoma cells].
    Cao F; Kang XH; Cui YH; Wang Y; Zhao KL; Wang YN; Kou WZ; Miao ZH; Cao XJ
    Zhonghua Zhong Liu Za Zhi; 2019 Jun; 41(6):435-440. PubMed ID: 31216829
    [No Abstract]   [Full Text] [Related]  

  • 16. Apelin promotes osteosarcoma metastasis by upregulating PLOD2 expression via the Hippo signaling pathway and hsa_circ_0000004/miR-1303 axis.
    Trang NTN; Lai CY; Tsai HC; Huang YL; Liu SC; Tsai CH; Fong YC; Tzeng HE; Tang CH
    Int J Biol Sci; 2023; 19(2):412-425. PubMed ID: 36632453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atractylenolide I inhibits colorectal cancer cell proliferation by affecting metabolism and stemness via AKT/mTOR signaling.
    Wang K; Huang W; Sang X; Wu X; Shan Q; Tang D; Xu X; Cao G
    Phytomedicine; 2020 Mar; 68():153191. PubMed ID: 32135457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors.
    Smit DJ; Cayrefourcq L; Haider MT; Hinz N; Pantel K; Alix-Panabières C; Jücker M
    Cells; 2020 Sep; 9(9):. PubMed ID: 32962206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLOD2 contributes to drug resistance in laryngeal cancer by promoting cancer stem cell-like characteristics.
    Sheng X; Li Y; Li Y; Liu W; Lu Z; Zhan J; Xu M; Chen L; Luo X; Cai G; Zhang S
    BMC Cancer; 2019 Aug; 19(1):840. PubMed ID: 31455288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.